세계 수산화알루미늄 시장은 예측 기간 동안 6.8%의 CAGR로 성장할 것으로 예상됩니다. 소화기 질환의 발생률 증가로 인해 전 세계적으로 소화기 질환으로 인한 사망자 수가 증가함에 따라 의약품 시장에서 수산화알루미늄의 수요가 증가하고 있습니다. 세계보건기구(WHO)에 따르면 2020년 미국에서만 소화기 질환으로 인한 사망자 수가 1,23,648명에 달했습니다. 영국에서는 2020년 31,588명에 달할 것으로 예상됩니다. 소화성 궤양 질환으로 인한 사망률 증가 미국에서는 2020년 사망자 수가 3780명으로 2019년 787명에서 증가했습니다. 수산화알루미늄은 소화성 궤양, 위염, 식도염, 식도열공탈장, 위산과다 등 환자의 증상을 치료하는 데 사용됩니다. 일부 시장 진입 기업들은 제산제(알루미늄-마그네슘)(R), 제산제 M(R), 제산제 현탁액(R), Gen-Alox(R), Maldroxal(R), Mylanta(R) Ultimate, Ri-Mox(R), Rulox(R) 등 수산화알루미늄 기반의 소화성 궤양 치료제를 제공하고 있습니다.
세계 수산화알루미늄 시장에서 제약 부문은 최종사용자 산업 중 가장 큰 비중을 차지할 것으로 예상됩니다. 이 부문의 성장은 고령화 인구의 증가, 소화기 건강에 대한 인식 증가, 위산 역류, 위식도 역류질환(GERD), 소화성 궤양과 같은 위장 질환의 증가에 기인합니다. 세계 소화기 질환기구에 따르면 여성의 49%, 남성의 36.6%가 모든 지역에서 최소 한 가지 이상의 기능성 위장 장애 기준을 충족하고 있으며, 기능성 변비 유병률은 11.7%, 기능성 소화불량증 유병률은 7.2%입니다. 또한 수산화알루미늄은 물과 유기 용매에 녹지 않기 때문에 위 분비물에서 염산을 중화시키는 제산제로 유용합니다. 수산화알루미늄은 알마콘, 더마그란, 젤실, 멀록스 플러스, 미아씨드, 미아씨드 더블 스트렝스, 민톡스 플러스 등 속쓰림, 산성 소화불량, 위산과다를 완화하는 데 사용되는 제산제입니다.
모든 지역 중 아시아태평양은 예측 기간 동안 수산화알루미늄 시장에서 큰 비중을 차지할 것으로 예상됩니다. 시장 성장을 촉진하는 주요 요인 중 하나는 건축, 자동차, 전자 등 다양한 산업에서 규제를 충족하고 화재 안전성을 높이기 위해 난연성 재료로 수산화알루미늄의 사용이 증가하고 있다는 점입니다. 또한, 시장 참여자들이 지속적으로 제휴, 협력, 인수에 나서고 있는 것도 이 지역의 시장 성장에 기여하고 있습니다. 예를 들어, 2022년 7월 Aluminum Corp.(Chalco)는 운남 알루미늄의 지분 19% 인수를 발표했습니다. 이 인수는 회사의 재무 성과를 강화하고, 가장 중요한 자산의 경쟁력과 가치를 높이고, 수산화알루미늄과 전해질 알루미늄 부문의 통합된 더 나은 경영을 목표로 하고 있습니다.
Title: Global Aluminum Hydroxide Market Size, Share & Trends Analysis Report by Type (Industrial Grade, Pharmaceutical Grade, and Others (Reagent grade)), and by End-User Industry (Plastics, Pharmaceuticals, Coatings, Adhesives, Sealants and Elastomers, and Others (Chemical))Forecast Period (2023-2030).
The global aluminum hydroxide market is anticipated to grow at a CAGR of 6.8% during the forecast period. The growing incidence of gastrointestinal disorders is driving the demand for aluminum hydroxide in the pharmaceutical market, which further results in increase in fatalities due to digestive diseases globally. According to the World Health Organization (WHO), in 2020, mortalities around 1,23,648 were caused due to digestive diseases only in the US. Additionally, in the UK the number reached up to 31,588 in 2020. Increasing mortality rate due to peptic ulcer disease In the US, the mortality number was 3780 in 2020 increased by 787 in 2019. Aluminum Hydroxide is used to treat symptoms in patients such as peptic ulcer, gastritis, esophagitis, hiatal hernia, or too much acid in the stomach (gastric hyperacidity). Some market players are offering aluminum hydroxide-based peptic ulcers treatments including Antacid (aluminum-magnesium)®, Antacid M®, Antacid Suspension®, Gen-Alox®, Maldroxal®, Mylanta® Ultimate, Ri-Mox®, Rulox®, and others.
The global aluminum hydroxide market is segmented based on its type and end-user industry. Based on its type, the market is sub-segmented into industrial grade, pharmaceutical grade, and others (reagent grade). Further, based on the end-user industry, the market is sub-segmented into plastics, pharmaceuticals, coatings, adhesives, sealants and elastomers, and others (chemical). Among the type, the industrial grade sub-segment is anticipated to hold a prominent market share, owing to the increasing use of aluminum hydroxide as a buffering agent in many industrial processes including agriculture, food processing, medicine, and photography.
Among the end-user industry, the pharmaceutical sub-segment is anticipated to hold a prominent share in the global aluminum hydroxide market. The segmental growth is led by the increasing aging population, rising awareness of digestive health, and increasing gastrointestinal disorder such as acid reflux, gastroesophageal reflux disease (GERD), and peptic ulcers. According to the World Gastroenterology Organization, 49% of females and 36.6% of males met criteria for at least one functional gastrointestinal disorders in all regions being functional constipation prevalence rates at 11.7%, functional dyspepsia prevalence rates at 7.2%. In addition, aluminum hydroxide is insoluble in water and organic solvents, which makes it useful as an antacid to neutralize hydrochloric acid in gastric secretions. Aluminum hydroxide is an antacid used such as Almacone, Derma Gran, Gelusil, Maalox Plus, Mi-acid, Mi-acid Double Strength, Mintox Plus for the relief of heartburn, acid indigestion, and sour stomach.
The global aluminum hydroxide market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). Among these, North America is anticipated to hold a prominent share over the forecast period, owing to the increasing usage in polymer applications, primarily as fire retardants, and increasing safety standards in building construction.
Among all the region, the Asia-Pacific region is anticipated to account for a significant share of the aluminum hydroxide market during the forecast period. One of the major factor driving the market growth includes the increasing use of aluminum hydroxide as a flame retardant material to meet the regulations and enhance fire safety across various industries, including construction, automotive, and electronics. In addition, the market players are continuously entering into partnership, collaboration and acquisition is also attributing to growth of market in this region. For instance, in July 2022, Aluminum Corp. of China Ltd. (Chalco) announced 19% acquisition of the shares of Yunnan Aluminum. The acquisition aims to strengthen the company's financial performance and raised the competitiveness and value of its most significant assets, and also integrated and better management in the aluminum hydroxide and electrolytic aluminum sectors.
The major companies serving the global aluminum hydroxide market include: TOR Minerals International Inc., Aluminum Corp. of China Ltd. (Chalco), Almatis B.V., Alteo Holding, Nabaltec AG, Huber Corp., LKAB Minerals AB, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2022, Hindalco Industries Ltd., signed an agreement with Phinergy and Indian Oil Corporation. The partnerships aims to start R&D and pilot production of aluminum plates, aluminum air-batteries, and recycling of aluminum.